Pseudo-endophthalmitis after intravitreal injection of triamcinolone

British Journal of Ophthalmology

Volumn 87, Issue 8, 2003, Pages 972-974

  Sutter, F K P ^a,b   Gillies, M C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CHLORAMPHENICOL; EYE OINTMENT; POVIDONE IODINE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE COURSE; DRUG FORMULATION; FEMALE; FUNGUS CULTURE; FUNGUS GROWTH; HUMAN; INFLAMMATION; MALE; OINTMENT; PAIN; PRIORITY JOURNAL; PSEUDOENDOPHTHALMITIS; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA EDEMA; RETROSPECTIVE STUDY; SIDE EFFECT; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VITREOUS DISEASE;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ENDOPHTHALMITIS; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 0041705920     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.8.972     Document Type: Article

References (10)

1. Antcliff RJ, Spalton DJ, Stanford MR, et al. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001;108:765-72.
2. Greenberg PB, Martidis A, Rogers AH et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86:247-8.
3. Jonas JB, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001;132:425-7.
4. Martidis A, Duker JS, Puliafito CA. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol 2001;119:1380-3.
5. Young S, Larkin G, Branley M, et al. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol 2001;29:2-6.
6. Gillies MC, Simpson JM, Luo W, et al. A randomized clinical trial of a single dose of intravitreal triamcinolone for neovascular age-related macular degeneration. One year results. Arch Opthalmol 2003;121:667-73.
7. Penfold PL, Gyory JF, Hunyor AB, et al. Exudative macular degeneration and intravitreal triamcinalone. A pilot study. Aust N Z J Ophthalmol 1995;23:293-8.
8. Ishibashi T, Miki K, Sorgente N et al. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 1985;103:708-11.
9. Hida T, Chandler D, Arena JE et al. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 1986;101:190-5.
10. McCuen B W 2nd, Bessler M, Tano Y, et al. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 1981;91:785-8.